Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: A European Narcolepsy Network study

Journal of Sleep Research

Volumn 22, Issue 5, 2013, Pages 482-495

  Luca, Gianina ^a   Haba Rubio, José ^b   Dauvilliers, Yves ^c,d   Lammers, Gert Jan ^e   Overeem, Sebastiaan ^f   Donjacour, Claire E ^e   Mayer, Geert ^g   Javidi, Sirous ^g   Iranzo, Alex ^h   Santamaria, Joan ^h   Peraita Adrados, Rosa ⁱ   Hor, Hyun ^a   Kutalik, Zoltan ^a,j   Plazzi, Giuseppe ^k   Poli, Francesca ^k   Pizza, Fabio ^k   Arnulf, Isabelle ^l   Lecendreux, Michel ^m   Bassetti, Claudio ⁿ   Mathis, Johannes ⁿ   Heinzer, Raphael ^b   Jennum, Poul ^o   Knudsen, Stine ^o   Geisler, Peter ^p   Wierzbicka, Aleksandra ^q   Feketeova, Eva ^r   Pfister, Corinne ^a   Khatami, Ramin ^s   Baumann, Christian ^t   Tafti, Mehdi ^a,b   Partinen, Markku ^u   Högl, Brigit ^u   Sonka, Karel ^u   Ferini Strambi, Luigi ^u   Riha, Renata ^u   more..

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c INSERM U1061   (France)

^d GUI DE CHAULIAC HOSPITAL   (France)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^g Hephata Clinic for Neurology   (Germany)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^m HÔPITAL ROBERT DEBRÉ   (France)

ⁿ UNIVERSITY OF BERN   (Switzerland)

^o UNIVERSITY OF COPENHAGEN   (Denmark)

^p UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^q INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^r FACULTY HOSPITAL   (Slovakia)

^s Clinic Barmelweid   (Switzerland)

^t UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^u NONE

more..

Author keywords

Age at onset; Diagnostic delay; Gender; Genome wide association

Indexed keywords

OREXIN A;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CATAPLEXY; CLINICAL ASSESSMENT; CLINICAL FEATURE; DAYTIME SOMNOLENCE; DELAYED DIAGNOSIS; DEMOGRAPHY; EPWORTH SLEEPINESS SCALE; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; ICSD-2; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; NARCOLEPSY WITH CATAPLEXY; ONSET AGE; POLYSOMNOGRAPHY; PREDICTOR VARIABLE; PRIORITY JOURNAL; REFERENCE DATABASE; REM SLEEP; RETROSPECTIVE STUDY; SEX DIFFERENCE; SLEEP; SLOW WAVE SLEEP;

AGE AT ONSET; DIAGNOSTIC DELAY; GENDER; GENOME-WIDE ASSOCIATION;

ADULT; AGE FACTORS; AGE OF ONSET; AGING; BODY MASS INDEX; CATAPLEXY; DELAYED DIAGNOSIS; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; POLYSOMNOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SEX FACTORS; SLEEP STAGES; TIME FACTORS; YOUNG ADULT;

EID: 84884127106     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/jsr.12044     Document Type: Article

References (53)

1. Aldrich, M. S., Chervin, R. D. and Malow, B. A. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep, 1997, 20: 620-629.
2. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd edn. American Academy of Sleep Medicine, Westcherter, IL, 2005.
3. Andlauer, O., Moore, H., Drake, C. et al. Short REM latency as screening tool for narcolepsy. Sleep, 2012, 35: A269.
4. Anic-Labat, S., Guilleminault, C., Kraemer, H. C., Meehan, J., Arrigoni, J. and Mignot, E. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep, 1999, 22: 77-87.
5. Aran, A., Lin, L., Nevsimalova, S. et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep, 2009, 32: 979-983.
6. Bassetti, C. and Aldrich, M. S. Idiopathic hypersomnia. A series of 42 patients. Brain, 1997, 8: 1423-1435.
7. Bassetti, C., Gugger, M., Bischof, M. et al. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med., 2003, 4: 7-12.
8. Baumann, C. R., Scammell, T. E. and Bassetti, C. L. Parkinson's disease, sleepiness and hypocretin/orexin. Brain, 2008, 131: e91.
9. Billiard, M. Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the International Classification of Sleep Disorders. 2nd edn.Sleep Med. Rev., 2007, 11: 377-388.
10. Broughton, R., Dunham, W., Weisskopf, M. and Rivers, M. Night sleep does not predict day sleep in narcolepsy. Electroencephalogr. Clin. Neurophysiol., 1994, 91: 67-70.
11. Cao, X., Pfaff, S. L. and Gage, F. H. YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev., 2008, 22: 3320-3334.
12. Carskadon, M. A., Dement, W. C., Mitler, M. M., Roth, T., Westbrook, P.R. and Keenan, S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep, 1986, 9: 519-524.
13. Chervin, R. D. and Aldrich, M. S. The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea. Neurology, 1999, 52: 125-131.
14. Chervin, R.D. and Aldrich, M.S. Sleep onset REM periods during multiple sleep latency tests in patients evaluated for sleep apnea. Am. J. Respir. Crit. Care Med., 2000, 161: 426-431.
15. Cvetkovic-Lopes, V., Bayer, L., Dorsaz, S. et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J. Clin. Invest., 2010, 120: 713-719.
16. Dauvilliers, Y., Molinari, N. and Calander, B. Delay of diagnosis of narcolepsy in a European and in a North American population. J. Sleep Res., 1998, 7: 56.
17. Dauvilliers, Y., Montplaisir, J., Molinari, N. et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology, 2001, 57: 2029-2033.
18. Dauvilliers, Y., Baumann, C. R., Carlander, B. et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J. Neurol. Neurosurg. Psychiatry, 2003, 74: 1667-1673.
19. Dodel, R., Peter, H., Spottke, A. et al. Health-related quality of life in patients with narcolepsy. Sleep Med., 2007, 8: 733-741.
20. Fronczek, R., Baumann, C. R., Lammers, G. J., Bassetti, C. L. and Overeem, S. Hypocretin/orexin disturbances in neurological disorders. Sleep Med. Rev., 2009, 13: 9-22.
21. Furuta, H., Thorpy, M. J. and Temple, H. M. Comparison in symptoms between aged and younger patients with narcolepsy. Psychiatry Clin. Neurosci., 2001, 55: 241-242.
22. Hor, H., Kutalik, Z., Dauvilliers, Y. et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat. Genet., 2010, 42: 786-789.
23. Jennum, P., Ibsen, R., Petersen, E. R., Knudsen, S. and Kjellberg, J. Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners. Sleep Med., 2012, 13: 1086-1093.
24. Kaplan, K. A. and Harvey, A. G. Hypersomnia across mood disorders: a review and synthesis. Sleep Med. Rev., 2009, 13: 275-285.
25. Knudsen, S., Jennum, P. J., Alving, J., Sheikh, S. P. and Gammeltoft, S. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Sleep, 2010, 33: 169-176.
26. Kok, S. W., Overeem, S., Visscher, T. L. et al. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes. Res., 2003, 11: 1147-1154.
27. Kornum, B. R., Kawashima, M., Faraco, J. et al. Common variants in P2RY11 are associated with narcolepsy. Nat. Genet., 2011, 43: 66-71.
28. Longstreth, W. T., Jr, Koepsell, T. D., Ton, T. G., Hendrickson, A. F. and van Belle, G. The epidemiology of narcolepsy. Sleep, 2007, 30: 13-26.
29. Mignot, E. Genetic and familial aspects of narcolepsy. Neurology, 1998, 50: S16-S22.
30. Mignot, E., Lin, L., Rogers, W. et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet., 2001, 68: 686-699.
31. Mignot, E., Lammers, G. J., Ripley, B. et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol., 2002, 59: 1553-1562.
32. Mignot, E., Lin, L., Finn, L. et al. Correlates of sleep-onset REM periods during the multiple sleep latency test in community adults. Brain, 2006, 129: 1609-1623.
33. Moldofsky, H., Broughton, R. J. and Hill, J. D. A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy. Sleep Med., 2000, 1: 109-116.
34. Morrish, E., King, M. A., Smith, I. E. and Shneerson, J. M. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med., 2004, 5: 37-41.
35. Morrison, I., Buskova, J., Nevsimalova, S., Douglas, N. J. and Riha, R. L. Diagnosing narcolepsy with cataplexy on history alone: challenging the International Classification of Sleep Disorders (ICSD-2) criteria. Eur. J. Neurol., 2011, 18: 1017-1020.
36. Nishino, S., Ripley, B., Overeem, S., Lammers, G. J. and Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 2000, 355: 39-40.
37. Ohayon, M. M., Priest, R. G., Caulet, M. and Guilleminault, C. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br. J. Psychiatry, 1996, 169: 459-467.
38. Ohayon, M.M., Zulley, J., Guilleminault, C. and Smirne, S. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology, 1999, 52: 1194.
39. Overeem, S., Dalmau, J., Bataller, L. et al. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology, 2004, 62: 138-140.
40. Overeem, S., van Nues, S. J., van der Zande, W. L., Donjacour, C. E., van Mierlo, P. and Lammers, G. J. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med., 2011, 12: 12-18.
41. Ozaki, A., Inoue, Y., Nakajima, T. et al. Health-related quality of life among drug-naive patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time. J. Clin. Sleep Med., 2008, 4: 572-578.
42. Parkes, J. D., Clift, S. J., Dahlitz, M. J., Chen, S. Y. and Dunn, G. The narcoleptic syndrome. J. Neurol. Neurosurg. Psychiatry, 1995, 59: 221-224.
43. Partinen, M. and Hublin, C. Epidemiology of sleep disorders. In: M. Kryger, T. Roth and W. C. Dement (Eds) Principles and Practice of Sleep Medicine. Elsevier Saunders, Philadelphia, 2011: 694-715.
44. Poli, F., Plazzi, G., Di Dalmazi, G. et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep, 2009, 32: 1491-1497.
45. Poli, F., Overeem, S., Lammers, G. et al. Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation. Vaccine, 2013, 31: 994-1007.
46. Ripley, B., Fujiki, N., Okura, M., Mignot, E. and Nishino, S. Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol. Dis., 2001a, 8: 525-534.
47. Ripley, B., Overeem, S., Fujiki, N. et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology, 2001b, 57: 2253-2258.
48. Rye, D. B., Dihenia, B., Weissman, J. D., Epstein, C. M. and Bliwise, D.L. Presentation of narcolepsy after 40. Neurology, 1998, 50: 459-465.
49. Sharpless, B. A. and Barber, J. P. Lifetime prevalence rates of sleep paralysis: a systematic review. Sleep Med. Rev., 2011, 15: 311-315.
50. Shpirer, I., Miniovitz, A., Klein, C. et al. Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study. Mov. Disord, 2006, 21: 1432-1438.
51. Singh, M., Drake, C. L. and Roth, T. The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep, 2006, 29: 890-895.
52. Sturzenegger, C. and Bassetti, C. L. The clinical spectrum of narcolepsy with cataplexy: a reappraisal. J. Sleep Res., 2004, 13: 395-406.
53. Vignatelli, L., D'Alessandro, R., Mosconi, P. et al. Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. Sleep Med., 2004, 5: 467-475.